CETP, cholesteryl ester transfer protein, 1071

N. diseases: 188; N. variants: 88
Source: ALL
Disease Type Disease Class Semantic Type N. genes d N. SNPs d Score gda EL gda EI gda N. PMIDs N. SNPs gda First Ref. Last Ref.
CUI: C3149462
Disease: HYPERALPHALIPOPROTEINEMIA 1
HYPERALPHALIPOPROTEINEMIA 1
disease Disease or Syndrome 9 4 0.800 limited 0.933 30 4 1990 2018
High density lipoprotein measurement
phenotype Laboratory Procedure 545 1440 0.100 None 1.000 25 61 2008 2019
CUI: C0428472
Disease: Serum HDL cholesterol measurement
Serum HDL cholesterol measurement
phenotype Laboratory Procedure 283 679 0.100 None 1.000 11 53 2008 2014
CUI: C1445957
Disease: Serum total cholesterol measurement
Serum total cholesterol measurement
phenotype Laboratory Procedure 486 1243 0.100 None 1.000 8 29 2010 2019
CUI: C1504336
Disease: Polypoidal choroidal vasculopathy
Polypoidal choroidal vasculopathy
disease Disease or Syndrome 56 67 0.060 None 1.000 6 2 2013 2018
CUI: C0202236
Disease: Triglycerides measurement
Triglycerides measurement
phenotype Laboratory Procedure 563 1418 0.100 None 1.000 4 16 2009 2018
CUI: C4524040
Disease: Atherogenic dyslipidaemia
Atherogenic dyslipidaemia
disease Disease or Syndrome 36 9 0.040 None 0.750 4 2004 2016
CUI: C3160761
Disease: Diabetic dyslipidaemia
Diabetic dyslipidaemia
disease Disease or Syndrome 28 11 0.030 None 1.000 3 1 2014 2017
Low density lipoprotein cholesterol measurement
phenotype Laboratory Procedure 483 1142 0.100 None 1.000 2 6 2012 2018
CUI: C1611743
Disease: Familial (FPAH)
Familial (FPAH)
disease Disease or Syndrome 1075 276 0.020 None 1.000 2 1993 1998
Oestrogen receptor positive breast cancer
disease Neoplastic Process 510 58 0.020 None 1.000 2 2015 2018
CUI: C4049446
Disease: Neointimal hyperplasia
Neointimal hyperplasia
disease Disease or Syndrome 198 0.020 None 1.000 2 2017 2019
CUI: C0005890
Disease: Body Height
Body Height
phenotype Organism Attribute 1903 3972 0.100 None 1.000 1 1 2019 2019
CUI: C0201657
Disease: C-reactive protein measurement
C-reactive protein measurement
phenotype Laboratory Procedure 135 624 0.100 None 1.000 1 2 2016 2016
CUI: C0201950
Disease: Cholesterol measurement test
Cholesterol measurement test
phenotype Laboratory Procedure 1 3 0.100 None 1.000 1 1 2010 2010
CUI: C0342890
Disease: Primary combined hyperlipidemia
Primary combined hyperlipidemia
disease Disease or Syndrome 1 0.010 None 1.000 1 2009 2009
CUI: C0428474
Disease: Serum LDL cholesterol measurement
Serum LDL cholesterol measurement
phenotype Laboratory Procedure 269 555 0.100 None 1.000 1 3 2012 2012
CUI: C0523465
Disease: Serum albumin measurement
Serum albumin measurement
phenotype Laboratory Procedure 433 3282 0.100 None 1.000 1 28 2012 2012
CUI: C0523744
Disease: Lipids measurement
Lipids measurement
group Laboratory Procedure 27 53 0.100 None 1.000 1 4 2009 2009
CUI: C0856169
Disease: Endothelial dysfunction
Endothelial dysfunction
phenotype Disease or Syndrome 716 25 0.010 None 1.000 1 2014 2014
CUI: C0857175
Disease: Postinfarction
Postinfarction
disease Disease or Syndrome 49 1 0.010 None 1.000 1 2010 2010
CUI: C1096293
Disease: Macroangiopathy
Macroangiopathy
disease Disease or Syndrome 31 6 0.010 None 1.000 1 2001 2001
CUI: C1168443
Disease: Pseudocholinesterase Measurement
Pseudocholinesterase Measurement
phenotype Laboratory Procedure 39 568 0.100 None 1.000 1 10 2011 2011
Differentiated Thyroid Gland Carcinoma
disease Neoplastic Process 245 80 0.010 None 1.000 1 2009 2009
CUI: C1963943
Disease: Atherothrombosis
Atherothrombosis
disease Acquired Abnormality 115 15 0.010 None 1.000 1 1 2009 2009